The University of Southampton
University of Southampton Institutional Repository

Intelligence and persisting with medication for two years: prospective analysis of a randomized controlled trial

Intelligence and persisting with medication for two years: prospective analysis of a randomized controlled trial
Intelligence and persisting with medication for two years: prospective analysis of a randomized controlled trial
The study examined whether verbal intelligence is associated with persisting to take medication for up to two years. The design is a prospective follow-up of compliance with taking medication in high-risk individuals participating in a randomised, placebo-controlled trial set in Central Scotland. Participants were 1993 people aged between 50 and 77 years with an ankle brachial index ? 0.95. The medication was 100 mg aspirin or placebo daily.
The principal outcome measure was continuing with taking medication or stopping it due to having ‘changed one's mind’. Higher verbal intelligence was associated with a greater likelihood of continuing to take medication up to two years after randomisation. For a standard deviation increase in Mill Hill Vocabulary Scale score, risk of stopping medication in the first two years of the study was 0.75 (95% CI 0.64 to 0.87, p < 0.001). Comparing the highest and lowest quartiles of IQ, the lowest IQ group's relative rate of stopping medication was 2.51 (95% CI 1.52 to 4.22). The effect was not attenuated after adjustment for sex, smoking, or level of deprivation. Verbal intelligence is associated with continuing, medium-to-long term engagement with health self-care, even in the face of uncertainty about whether active treatment is being received, whether the treatment is known to be effective in general, and whether it will be helpful to the individual taking it. Such persisting with potentially helpful health behaviours in the face of uncertainty might partly explain why people with higher intelligence live longer and suffer less morbidity from chronic diseases.
607-612
Deary, I.J.
e3403cfe-eb5b-4941-903d-87ef0db89c60
Gale, C.R.
5bb2abb3-7b53-42d6-8aa7-817e193140c8
Stewart, M.
5c99c553-ecbb-46e2-8806-60fa19f11b02
Fowkes, G.
1c73a647-5c2e-4d46-86b1-f3f609fbdffb
Murray, G
fd902194-c32e-4857-ba95-20c441f26beb
Batty, G.D.
bf322937-2cfb-4174-b5cb-dc016f0d0b8a
Price, J.
5649fe7d-4769-42aa-b6ea-06662c7e3ea4
Deary, I.J.
e3403cfe-eb5b-4941-903d-87ef0db89c60
Gale, C.R.
5bb2abb3-7b53-42d6-8aa7-817e193140c8
Stewart, M.
5c99c553-ecbb-46e2-8806-60fa19f11b02
Fowkes, G.
1c73a647-5c2e-4d46-86b1-f3f609fbdffb
Murray, G
fd902194-c32e-4857-ba95-20c441f26beb
Batty, G.D.
bf322937-2cfb-4174-b5cb-dc016f0d0b8a
Price, J.
5649fe7d-4769-42aa-b6ea-06662c7e3ea4

Deary, I.J., Gale, C.R., Stewart, M., Fowkes, G., Murray, G, Batty, G.D. and Price, J. (2009) Intelligence and persisting with medication for two years: prospective analysis of a randomized controlled trial. Intelligence, 37 (6), 607-612. (doi:10.1016/j.intell.2009.01.001). (Submitted)

Record type: Article

Abstract

The study examined whether verbal intelligence is associated with persisting to take medication for up to two years. The design is a prospective follow-up of compliance with taking medication in high-risk individuals participating in a randomised, placebo-controlled trial set in Central Scotland. Participants were 1993 people aged between 50 and 77 years with an ankle brachial index ? 0.95. The medication was 100 mg aspirin or placebo daily.
The principal outcome measure was continuing with taking medication or stopping it due to having ‘changed one's mind’. Higher verbal intelligence was associated with a greater likelihood of continuing to take medication up to two years after randomisation. For a standard deviation increase in Mill Hill Vocabulary Scale score, risk of stopping medication in the first two years of the study was 0.75 (95% CI 0.64 to 0.87, p < 0.001). Comparing the highest and lowest quartiles of IQ, the lowest IQ group's relative rate of stopping medication was 2.51 (95% CI 1.52 to 4.22). The effect was not attenuated after adjustment for sex, smoking, or level of deprivation. Verbal intelligence is associated with continuing, medium-to-long term engagement with health self-care, even in the face of uncertainty about whether active treatment is being received, whether the treatment is known to be effective in general, and whether it will be helpful to the individual taking it. Such persisting with potentially helpful health behaviours in the face of uncertainty might partly explain why people with higher intelligence live longer and suffer less morbidity from chronic diseases.

This record has no associated files available for download.

More information

Submitted date: 2009

Identifiers

Local EPrints ID: 69960
URI: http://eprints.soton.ac.uk/id/eprint/69960
PURE UUID: 6fad9982-03c8-409c-870c-0b181862f7c5
ORCID for C.R. Gale: ORCID iD orcid.org/0000-0002-3361-8638

Catalogue record

Date deposited: 05 Jan 2010
Last modified: 14 Mar 2024 02:38

Export record

Altmetrics

Contributors

Author: I.J. Deary
Author: C.R. Gale ORCID iD
Author: M. Stewart
Author: G. Fowkes
Author: G Murray
Author: G.D. Batty
Author: J. Price

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×